Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SOdium-Glucose Cotransporter 2 Inhibitor With and Without an ALDosterone AntagonIst for Heart Failure With Preserved Ejection Fraction: a Two-centre Randomised Crossover Trial

NCT05676684 is registered in ClinicalTrials.gov with Universidade do Porto as lead sponsor.

NCT NCT05676684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05676684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SOdium-Glucose Cotransporter 2 Inhibitor With and Without an ALDosterone AntagonIst for Heart Failure With Preserved Ejection Fraction: a Two-centre Randomised Crossover Trial
Lead sponsor
Universidade do Porto
Phase
Phase 2/3
Overall status
Completed
Start date
September 15, 2022
Completion date
November 29, 2024
Enrollment
108 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction